Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $275.00 to $277.00. They now have an "outperform" rating on the stock.
Pharma Wholesale and Distribution Market 10 Year Forecast Report 2024-2034: Global Market Set to Surpass the US$800 Billion Mark in 2024 [Yahoo! Finance]
Cencora Reports Fiscal 2024 Second Quarter Results
Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Citigroup Inc. from $265.00 to $280.00. They now have a "buy" rating on the stock.